You are part of our success: AlmirallShare results

Published on 11/02/2019

More than 450 scientists subscribed and over 170 different proposals received

Digital + omics = unprecedented target-disease associations

Published on 23/01/2019

Partnership between Almirall, S.A. and Barcelona Supercomputing Center (BSC) to identify novel targets to treat dermatological diseases

SilicoDerm: new modeling techniques for dermatological research

Published on 31/10/2018

SilicoDerm computational methodologies will facilitate the identification of active compounds for the treatment of inflammatory skin diseases

Almirall + Evotec = first-in-class dermatological therapies

Published on 30/10/2018

Almirall S.A. and Evotec AG have entered into a research collaboration to discover and develop first-in-class therapies for debilitating dermatology diseases